Out of stock

This item is currently unavailable

Sold out. We send one email the moment it's back.

Out of stock 1 day

World Outlook for Tyrosine Kinase Inhibitors 2025-2030

Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

No price data yet

Price history will appear here once data is collected from Amazon.

View at Amazon ↗
Out of stock

Price data checked 1 day ago

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

No price data available for histogram

Description

The 2025-2030 World Outlook for Tyrosine Kinase Inhibitors provides a comprehensive analysis of the global market landscape. Published by ICON Group International, Inc., this industry report covers developments and trends expected to shape the sector through 2030. It serves as a professional resource for understanding the trajectory of tyrosine kinase inhibitor technologies and market dynamics on a global scale.

Key Features

Covers the global market outlook for Tyrosine Kinase Inhibitors from 2025 to 2030.

Authored and published by ICON Group International, Inc.

Provides a specialized perspective on the Tyrosine Kinase Inhibitors industry.

Designed for professional use within the medical and pharmaceutical book categories.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
03 March 2024
Listed Since
08 April 2024

Similar Products You Might Like

The 2023-2028 World Outlook for Tyrosine Kinase Inhibitors
99% match

The 2023-2028 World Outlook for Tyrosine Kinase Inhibitors

£795.00 31 Oct 2026
The 2023-2028 Outlook for Tyrosine Kinase Inhibitors in Japan
99% match

The 2023-2028 Outlook for Tyrosine Kinase Inhibitors in Japan

£495.00 04 Nov 2026
Tyrosine Kinase Inhibitors Outlook 2023-2028 - US Market
99% match

Tyrosine Kinase Inhibitors Outlook 2023-2028 - US Market

£520.00 05 Nov 2026
Tyrosine Kinase Inhibitors Outlook in India 2023-2028
98% match

Tyrosine Kinase Inhibitors Outlook in India 2023-2028

£515.00 05 Nov 2026
The 2023 Report on Tyrosine Kinase Inhibitors: World Market Segmentation by City
97% match

The 2023 Report on Tyrosine Kinase Inhibitors: World Market Segmentation by City

£795.00 31 Oct 2026
Tyrosine Kinases as Druggable Targets in Cancer
97% match

Tyrosine Kinases as Druggable Targets in Cancer

IntechOpen

£118.98 10 Sep 2026
Receptor Tyrosine Kinases: Family and Subfamilies - Springer
96% match

Receptor Tyrosine Kinases: Family and Subfamilies - Springer

Springer

£147.81 13 Sep 2026
Protein Tyrosine Phosphatases: Methods and Protocols: 2743 (Methods in Molecular Biology, 2743)
96% match

Protein Tyrosine Phosphatases: Methods and Protocols: 2743 (Methods in Molecular Biology, 2743)

Humana

£155.70 07 Nov 2026
The 2026-2031 World Outlook for Antidepressant and Anti-Anxiety Drugs
95% match

The 2026-2031 World Outlook for Antidepressant and Anti-Anxiety Drugs

£885.00 02 Nov 2026
World Outlook for Advanced Therapy Medicinal Products 2025-2030
95% match

World Outlook for Advanced Therapy Medicinal Products 2025-2030

Price unavailable
Role of Tyrosine Kinases in Gastrointestinal Malignancies
95% match

Role of Tyrosine Kinases in Gastrointestinal Malignancies

Springer

£89.99 23 Sep 2026
The 2021-2026 World Outlook for Psychotherapeutic Agents Excluding Tranquilizers and Antidepressants
95% match

The 2021-2026 World Outlook for Psychotherapeutic Agents Excluding Tranquilizers and Antidepressants

£795.00 28 Oct 2026
Huntington's Disease Therapeutics World Outlook 2025-2030
95% match

Huntington's Disease Therapeutics World Outlook 2025-2030

Price unavailable
The 2026-2031 World Outlook for Antidepressants for Anxiety Disorders
95% match

The 2026-2031 World Outlook for Antidepressants for Anxiety Disorders

£885.00 04 Nov 2026
The 2013-2018 Outlook for Respiratory and Cerebral Central Nervous System Stimulants and Anorexiants Excluding Amphetamines in India
95% match

The 2013-2018 Outlook for Respiratory and Cerebral Central Nervous System Stimulants and Anorexiants Excluding Amphetamines in India

£495.00 30 Oct 2026
US Antidepressants for Anxiety Disorders Outlook 2023-2028
95% match

US Antidepressants for Anxiety Disorders Outlook 2023-2028

£520.00 10 Nov 2026
Design, Synthesis & Anticancer screening of Novel 2-Phenazinamines: Design, Synthesis and Anticancer screening of some New 2-Phenazinamines as Bcr-Abl Tyrosine kinase Inhibitors
95% match

Design, Synthesis & Anticancer screening of Novel 2-Phenazinamines: Design, Synthesis and Anticancer screening of some New 2-Phenazinamines as Bcr-Abl Tyrosine kinase Inhibitors

LAP Lambert Academic Publishing

£80.00 08 Sep 2026
The 2023-2028 Outlook for Digital Therapeutic (DTx) in China
95% match

The 2023-2028 Outlook for Digital Therapeutic (DTx) in China

£495.00 16 Nov 2026
World Outlook for Therapeutics Proteins 2025-2030 Report
95% match

World Outlook for Therapeutics Proteins 2025-2030 Report

Price unavailable
The 2016-2021 Outlook for Respiratory and Cerebral Central Nervous System Stimulants and Anorexiants Excluding Amphetamines in Greater China
95% match

The 2016-2021 Outlook for Respiratory and Cerebral Central Nervous System Stimulants and Anorexiants Excluding Amphetamines in Greater China

£595.00 11 Nov 2026
Japan CNS Stimulants and Anorexiants Market Outlook Study
95% match

Japan CNS Stimulants and Anorexiants Market Outlook Study

£595.00 08 Sep 2026
The 2023-2028 Outlook for Digital Therapeutic (DTx) in Japan
95% match

The 2023-2028 Outlook for Digital Therapeutic (DTx) in Japan

£495.00 01 Oct 2026
The 2013-2018 Outlook for Drugs for Alzheimer's and Parkinson's Diseases in Asia
95% match

The 2013-2018 Outlook for Drugs for Alzheimer's and Parkinson's Diseases in Asia

£325.00 21 Oct 2026
The 2013-2018 Outlook for Drugs for Alzheimer's and Parkinson's Diseases in Latin America
95% match

The 2013-2018 Outlook for Drugs for Alzheimer's and Parkinson's Diseases in Latin America

£325.00 02 Oct 2026